- Report
- December 2024
- 100 Pages
United States
From €5451EUR$5,950USD£4,632GBP
- Report
- November 2023
- 152 Pages
Global
From €4122EUR$4,500USD£3,504GBP
- Report
- January 2023
- 152 Pages
Global
From €2061EUR$2,250USD£1,752GBP
- Report
- November 2020
- 80 Pages
Global
From €779EUR$850USD£662GBP
- Report
- March 2024
- 342 Pages
Global
From €5451EUR$5,950USD£4,632GBP
- Report
- November 2021
- 100 Pages
United Kingdom
From €5451EUR$5,950USD£4,632GBP
- Report
- March 2025
- 85 Pages
Saudi Arabia
From €3206EUR$3,500USD£2,725GBP
From €3206EUR$3,500USD£2,725GBP
From €3206EUR$3,500USD£2,725GBP
- Report
- December 2024
- 80 Pages
India
From €3206EUR$3,500USD£2,725GBP
- Report
- October 2023
- 146 Pages
Global
From €3231EUR$3,528USD£2,746GBP
€3802EUR$4,150USD£3,231GBP
- Report
- February 2023
- 240 Pages
Global
From €2289EUR$2,499USD£1,946GBP
€3270EUR$3,570USD£2,779GBP

Pharmaceutical Services Outsourcing (PSO) is a rapidly growing market within the pharmaceutical manufacturing industry. It involves the transfer of certain activities, such as drug development, clinical trials, and manufacturing, from pharmaceutical companies to third-party service providers. This allows pharmaceutical companies to focus on their core competencies while outsourcing non-core activities to specialized service providers. PSO also helps pharmaceutical companies reduce costs, increase efficiency, and improve quality.
The PSO market is segmented into drug development, clinical trials, and manufacturing services. Drug development services include pre-clinical and clinical research, regulatory affairs, and drug safety. Clinical trials services include clinical trial management, data management, and biostatistics. Manufacturing services include active pharmaceutical ingredient (API) manufacturing, finished dosage form (FDF) manufacturing, and packaging and labeling.
Notable companies in the PSO market include Parexel, Quintiles, Covance, PRA Health Sciences, and Charles River Laboratories. Show Less Read more